Project Grant HT94252310095
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
Baylor College of Medicine will use a $1.56 million project grant from the Defense Health Agency to research germline variants and population-wide breast cancer risk. The grant was awarded on February 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through this four-year award, Baylor College of Medicine will investigate medical solutions for breast cancer through innovative and impactful research aimed at transforming health care for service members and the...
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
This $1,200,000 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research conducted by Baylor College of Medicine to develop a bone-targeting E-cadherin antibody nanogel to eliminate bone metastasis. The award period runs from April 1, 2025 to March 31, 2028. Baylor College of Medicine, a private non-profit research university, has extensive experience delivering specialized medical research and...
This federal Project Grant award of $2,239,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to investigate the progression from ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer driven by the N-RAS gene. The research project aims to advance the understanding of this disease process with the potential to lead to improved diagnostic and treatment approaches. The award...
This $440,000 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by Baylor College of Medicine on the use of biopolymers for intestinal healing and immune modulation to treat inflammatory bowel disease. The award period is from January 15, 2025 to January 14, 2027. Baylor College of Medicine, a private non-profit research university, will conduct this advanced biomedical research initiative...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
The Department of the Army Medical Command awarded a $1,065,567 project grant to Baylor College of Medicine to develop a novel therapeutic strategy for prostate cancer in African American men. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and impactful medical solutions. Funding will support Baylor College of Medicine's...